Exhibit 5.1

Orphazyme A/S
Ole Maaløes Vej 3
DK-2200 Copenhagen N
Denmark
(the “Company”)
Date: 15 October 2021
Dear Madams and Sirs,
Orphazyme A/S – Registration Statement on Form F-3 filed with the United States Securities and Exchange Commission
We have acted as Danish legal counsel to Orphazyme A/S, company reg. no. (CVR) 32 26 63 55 (the “Company”) with respect to a potential offering, issuance and sale by the Company from time to time in one or more offerings of ordinary shares with a nominal value of DKK 1 per share (the “Underlying Shares”), which may be represented by American Depositary Shares (“ADSs”), each such ADS representing one ordinary share, and any such ADSs having an aggregate offering price of up to $ 75,000,000 (the “Offering” or “Offerings”).
Any such Underlying Shares are expected to be admitted to trading and official listing on Nasdaq Copenhagen A/S (“Nasdaq Copenhagen”) and any such ADSs are expected to be listed on the Nasdaq Global Select Market in the United States (“Nasdaq Global”).
This opinion (the “Opinion”) is being furnished in connection with the registration statement, as the same may be amended from time to time, (the “Registration Statement”) on Form F-3 filed by the Company with the Securities and Exchange Commission on 15 October 2021 pursuant to the Securities Act of 1933, as amended (the “Securities Act”).
1 | For the purpose of this Opinion we have examined the following documents and performed the following investigations: |
| a) | a copy of the Registration Statement; |
| b) | a copy of the articles of association of the Company dated 25 March 2021 (the “Articles of Association”); |
| c) | a copy of the minutes of the annual general meeting of the Company held on 25 March 2021 whereby the annual general meeting adopted an authorization to the Board of Directors to increase the Company’s share capital without preemption rights for existing shareholders by a nominal amount of up to DKK 6,989,767; |
Axel Towers, Axeltorv 2, 1609 Copenhagen V, Denmark
+45 33 41 41 41, gorrissenfederspiel.com | Advokatpartnerselskab, VAT 38 05 24 97
